Cervical cancer screening study for women aged 25 to 65
Part of Cancer, Women’s health & pregnancy clinical trials.
This study compares two methods for finding early signs of cervical cancer during a routine exam. It may help doctors detect problems sooner and prevent cancer from developing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman between 25 and 65 years old.
- You have not been pregnant during the screening.
- You are not bleeding from the vagina at the time of the exam.
- You have not had any past treatment for cervical lesions.
- You are able to give your informed consent and cooperate with the exam.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at better ways to manage early precancerous changes in the cervix (called high-grade lesions) without surgery. It aims to find which approaches work best for women who have not been vaccinated against HPV.
This study compares different ways to screen for cervical cancer in women living with HIV. It aims to find the most effective and practical screening approach for this group.
This study looks at ways to improve cervical cancer screening for women. If you join, you may help researchers find better methods for early detection, which can lead to earlier treatment and better outcomes.
This study tests a new technology to help find cervical cancer earlier by focusing on people who already had an abnormal screening result. It may help improve how abnormal tests are checked and diagnosed.
This trial checks whether “therapy abstention” (not treating right away) and close monitoring is safe for certain high-grade cervical cell changes. It may help some people avoid immediate procedures while still catching any progression early.
This trial compares a liquid-based cytology test with a molecular screening test to find early changes in the cervix that could lead to cancer. It may help you understand which test is better at detecting these changes before they become serious.
Hear when a new Cervical Intraepithelial Neoplasia (CIN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.